Pay in 4 interest-free payments of $6.59 Learn more
Ships within 48 hours · Estimated delivery Aug 27 - Sep 1
Why Weight Loss Matters Many of the health improvements tied to GLP-1 medications are linked to their weight loss effects
The minimum BMI for semaglutide (Wegovy) under FDA labeling is 30 without any additional conditions, or 27 with at least one weight-related comorbidity such as type 2 diabetes, hypertension, or dyslipidemia
While both are related to GLP-1 receptor agonist therapy, they may be prescribed for different health goals and treatment plans
Psychological & Physiological Dependence Patients may develop a psychological or physiological reliance on GLP-1 medications, complicating the discontinuation process
The FDA announcement also suggests that its July 2026 meeting will, in short order, explore giving these peptides full approval
US$ 28.52
US$ 22.02
US$ 21.34
US$ 29.67
US$ 22.80
US$ 26.94
US$ 28.24
